Florida has acquired thousands of monoclonal antibody treatments on its own after the Biden administration rationed federal doses. Gov. Ron DeSantis (R-Fla.) announced on Thursday that the Sunshine State reached a deal for 3,000 doses with pharmaceutical company GlaxoSmithKline.
“We’re going to be able to use that sotrovimab to bridge some of the gaps that are going to be developing as a result of the Biden administration dramatically cutting medications to the state of Florida,” explained DeSantis.
DeSantis said he was excited when Joe Biden announced the federal government would be increasing shipments of monoclonal antibodies to states by 50 percent. However, the treatments were distributed evenly among all states regardless of demand, resulting in less shipments for Florida.